Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-2635

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-2635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352635)

This text provides information about a medication in the form of orally disintegrating tablets containing Ondansetron USP 8 mg. It states the presence of phenylalanine per tablet and gives storage instructions. The package is equipped with a child-resistant feature and meets USP Disintegration Test 2. Additionally, it mentions to scan a QR code for more details on dosage and administration. The tablets are dispensed in a blister pack and should not be removed until right before use. The medication is from Bryant Ranch Prepack, Inc. and Glenmark Pharmaceuticals.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

FDA Label Image

Structure-hcl (Structure HCl)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.